AEMD - Aethlon Medical Inc logo

Aethlon Medical Inc

AEMD

Aethlon Medical develops immunotherapeutic devices targeting cancer and viral infections. Its primary product, the Hemopurifier, aims to remove cancer-promoting exosomes and various viruses from blood, with applications in organ transplantation and clinical trials.

โš•๏ธ Healthcare NASDAQ Listed 2001 $ USD
$1,000 invested 20 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth2.99%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.5
Net Growth33.40%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth4.65%
Net Trend30%
Net Income Consistency
Rev Growth-100.00%
Rev Trend40%
Revenue Consistency
20 Years
Scoreโ€”
Net Growth-15.15%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend40%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-56.85%
Net Trend42%
Net Income Consistency
Rev Growthโ€”
Rev Trend40%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Aethlon Medical Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by Net Income Growth.

Has not reached the top 50 on Net Income Growth in any year we have ranked.

  • AEMD

2011: 76.6% ยท 2021: 66.5% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 5.07โ€”
1 Year2025-10-21
$ 25.10-79.80%
5 Years2021-10-21
$ 14.32K-99.96%
10 Years2016-10-21
$ 287.4K-100.00%
20 Years2006-10-20
$ 780K-100.00%
All Time2001-01-02
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 6M$ 4.93B
2026$ 0.00-$ 7M$ 5M
2025$ 0.00-$ 13M$ 5M
2024$ 0.00-$ 12M$ 5M
2023$ 574.25K-$ 12M$ 14M
2022$ 294.17K-$ 10M$ 17M
2021$ 659.1K-$ 7M$ 9M
2020$ 650.19K-$ 6M$ 9M
2019$ 229.63K-$ 6M$ 3M
2018$ 149.63K-$ 5M$ 6M
2017$ 392.07K-$ 7M$ 1M
2016$ 886.57K-$ 4M$ 2M
2015$ 762.42K-$ 6M$ 855.6K
2014$ 1M-$ 13M$ 1M
2013$ 1M-$ 4M$ 125.27K
2012$ 1M-$ 8M$ 143.91K
2011-$ 5M$ 15.7K
2010-$ 4M$ 67.95K
2009-$ 6M$ 6.16K
2008-$ 4M$ 254.69K
2007-$ 6M$ 440.11K
2006-$ 2M$ 836.38K
2005-$ 2M$ 8.63K
2004-$ 1M$ 1.62K
2003-$ 2M$ 6.33K
2002-$ 3M$ 10.67K
IPO2001-$ 4M$ 6.06K
AEMD - Aethlon Medical Inc logo

Aethlon Medical Inc fundamental performance

Between 2021 and 2026, revenue declined from $ 659.1K to $ 0.00 and net income went from -$ 7M to -$ 7M. Revenue increased in 1 of those 5 years; net income in 2.

Between 2016 and 2026, revenue declined from $ 886.57K to $ 0.00 and net income went from -$ 4M to -$ 7M. Revenue increased in 4 of those 10 years; net income in 3.

Aethlon Medical Inc currently holds a 5-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.

Membership

Continue AEMDโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies